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0929-6441/ª 2014, Elsevier Taiwan LLIt is uncommon to diagnose fetal hepatic hemangioma during the antenatal period. We
describe herein two patients with a giant hepatic hemangioma detected antenatally, both with
perinatal complications. In Case 1, a fetal intra-abdominal mass, measur ing
63 mm  50 mm  74 mm, was observed below the right lobe of the liver, and the presumptive
antenatal diagnosis of hepatic hemangioma was made at 37 weeks of gestation. Antenatal im-
aging suggested an intratumoral hemorrhage, but postnatal clinical findings refuted this diag-
nosis. However, progressive thrombocytopenia and coagulopathy were noted just after birth,
resulting in the diagnosis of KasabacheMerritt syndrome. In Case 2, our ultrasound examina-
tion performed at 40 weeks of gestation revealed a mixed solid and cystic hepatic tumor,
measuring 99 mm  54 mm. Further, antenatal sonography revealed cardiomegaly, increased
descending-aorta velocity, atrioventricular valvular regurgitation, and a dilated inferior vena
cava, suggesting high-output cardiac insufficiency. Giant hepatic hemangiomas can lead to se-
vere complications such as cardiac insufficiency and KasabacheMerritt syndrome, and these
complications may occur during the fetal or early neonatal period. Detailed prenatal evalua-
tion using fetal imaging and cord-blood sampling is important to determine proper antenatal
management of patients with giant hepatic hemangiomas and to allow for prompt postnatal
treatment.
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Fetal Hepatic Hemangioma 47IntroductionFig. 1 T2-weighted coronal magnetic resonance imaging of a
giant fetal hepatic hemangioma (arrows) at 37 weeks of
gestation.Hepatic tumors account for approximately 5% of childhood
neoplasms [1]. Infantile hemangioma is the most common
primary hepatic neoplasm, followed, in order, by mesen-
chymal hamartoma and hepatoblastoma [2]. Small hepatic
hemangiomas are usually asymptomatic and seldom require
therapy. Giant hepatic hemangiomas, defined by a diam-
eter of >4 cm, are rare but can lead to severe complica-
tions, including consumptive thrombocytopenic
coagulopathy (KasabacheMerritt syndrome) [3], intra-
abdominal hemorrhage due to tumor rupture, and high-
output congestive heart failure due to arteriovenous
shunting [4]. It is uncommon to diagnose fetal hepatic
hemangiomas during the antenatal period, but we
encountered two such patients, with complications mani-
festing during the antenatal or early neonatal period.
Case Reports
Case 1
A 33-year-old primiparous woman was referred to us at
37 weeks and 6 days of gestation for evaluation of a fetal
abdominal mass. Our ultrasound examination revealed a
single fetus of a size consistent with her estimated date of
confinement. A fetal intra-abdominal mass, measuring
63 mm  50 mm  74 mm, was observed below the right
lobe of the liver. The mass contained cystic and solid areas,
and a distinct border between the mass and the liver was not
obvious. There was no evidence of hydrops. Fetal magnetic
resonance imaging (MRI) demonstrated a mass, with low T1
and inhomogeneous high T2 signal intensity, originating from
the right lobe of the liver (Fig. 1). The presumptive ante-
natal diagnosis was hepatic hemangioma. Six hours after the
first ultrasound, the size of the fetal abdominal mass was re-
evaluated and found to be 90 mm  72 mm  76 mm.
Doppler imaging showed hypervascularity (Fig. 2). Increased
systolic peak velocity in the middle cerebral artery (94 cm/
s; 1.67 MoM) was also noted. The possibility of progressive
fetal anemia due to intratumoral hemorrhage could not be
excluded, and we decided to perform emergent cesarean
delivery.
A female infant weighing 2536 g was delivered, with an
Apgar score of 5 at 1 minute and an Apgar score of 7 at
5 minutes. Retractions and grunting respirations were
noted in the newborn, but she did not need mechanical
ventilatory support. After stabilization, the infant was
transferred to the neonatal intensive care unit for further
treatment. Her initial laboratory data showed thrombocy-
topenia (platelet count, 8.7  104/mL), and coagulopathy
[prothrombin time percentage (PT%), 60%; international
normalized ratio (INR), 1.34; activated partial thrombo-
plastin time (aPTT), 58.1 s; fibrinogen, 143 mg/dL; fibrin
degradation products, 76.2 mg/min; D-dimer, 36.5 mg/mL].
The patient was mildly anemic, with a hemoglobin level of
12.7 g/dL. As this value did not worsen, the prenatal sus-
picion of intratumoral hemorrhage was not borne out.
Computed tomography examination on the 2nd day of life
demonstrated an 8-cm mass emanating from the right lobe
of the liver. After administration of intravenous contrast,the lesion demonstrated peripheral enhancement with
centripetal filling. The hepatic artery was markedly dilated
(Fig. 3). Based on these findings, we confirmed the diag-
nosis of hepatic hemangioma. The infant gradually devel-
oped thrombocytopenia and coagulopathy. A blood sample
taken on the 2nd day of life showed the following results:
platelet count, 4.7  104/mL; PT%, 66%; INR, 1.32; aPTT,
90.4 seconds; fibrinogen, 92 mg/dL; fibrin degradation
products, 92.1 mg/min; D-dimer, 46.2 mg/mL. These findings
were compatible with disseminated intravascular coagula-
tion, and we diagnosed KasabacheMerritt syndrome. The
infant’s thrombocytopenia and coagulopathy were inten-
sively treated with the administration of fresh frozen
plasma, antithrombin, gabexate mesilate, and propranolol.
The platelet count gradually stabilized and the coagulop-
athy resolved, and the baby was discharged home on
Postpartum Day 67 with a platelet count of 22.1  104/mL.
Over 5 months of follow-up and propranolol treatment, the
neoplasm has grown smaller.
Case 2
A 44-year-old primiparous Japanese woman was referred to
us at 40 weeks and 1 day of gestation because a fetal intra-
abdominal mass had been identified on routine ultrasono-
graphic examination. Our ultrasound examination revealed
Fig. 2 Transverse section on ultrasound demonstrating an abdominal mass.
48 H. Imai et al.a mixed solid and cystic mass, measuring 99 mm  54 mm,
with small punctate calcifications in the left upper
abdomen, anterior to the stomach, of the fetus. The mass
was thought to arise from the left lobe of the liver (Fig. 4A).
Color and pulsed Doppler imaging showed extensive
vascularization within the neoplasm (Fig. 4B). The hepatic
artery supplied the mass. The descending aorta showed an
increased peak velocity (181.21 cm/s), and the fetus had
cardiomegaly, with a cardiothoracic area ratio of 43%,
suggesting that fetal cardiac insufficiency was caused by
the hyperdynamic state. The inferior vena cava was
dilated, but neither polyhydramnios nor fetal hydrops was
noted. Detailed fetal echocardiography revealed normal
heart anatomy with tricuspid valvular regurgitation. The
abdominal circumference was greater than the 90th
percentile for gestational age, but the biparietal diameter
was consistent with the estimated date of confinement.
The umbilical and fetal arterial and venous Doppler indicesFig. 3 (A) Transverse and (B) frontal computed tomography on t
the right lobe of the liver. The lesion shows peripheral enhancem
contrast.were normal. At 40 weeks and 2 days of gestation, we
performed cord-blood sampling. The fetal blood had a
normal platelet count and coagulation parameters, and
there were no signs of hemolysis (platelet count,
19.1  104/mL; PT%, 41%; INR, 1.78; aPTT, 41.8 seconds).
There was no evidence of severe fetal anemia as the cause
of the heart failure (hemoglobin, 11.1 g/dL; hematocrit,
35.9%). The cardiomegaly was thought to be caused by the
hyperdynamic state of the fetus. At 40 weeks and 3 days,
the patient went into spontaneous labor. Unfortunately,
the cardiotocogram showed frequent variable de-
celerations, and the decision was made to perform emer-
gent cesarean delivery.
A 3180 g male infant was delivered, with an Apgar score
of 5 at 1 minute and an Apgar score of 7 at 5 minutes. The
infant had marked abdominal distention, but his respiratory
condition was good and ventilatory support was unnec-
essary. After stabilization, the infant was transferred to thehe 2nd day of life demonstrating an 8-cm mass emanating from
ent with centripetal filling after administration of intravenous
Fig. 4 (A) Transverse ultrasound examination reveals a 99 mm e 54 mm mixed solid and cystic mass with small punctate cal-
cifications. The mass is located in the left upper abdomen of the fetus, anterior to the stomach, and appears to arise from the left
lobe of the liver. (B) Color and pulsed Doppler imaging shows extensive vascularization within the neoplasm.
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radiography demonstrated cardiomegaly without abnor-
malities in the lung fields (Fig. 5). Computed tomography
showed an 8-cm mass emanating from the left lobe of the
liver. The lesion revealed peripheral enhancement with
centripetal filling after intravenous contrast administra-
tion. MRI showed T1-weighted hypointense tumors, with
relatively marked hyperintensity on T2-weighted images,
along with contrast enhancement after gadolinium admin-
istration (Fig. 6). Based on these findings, the clinical
diagnosis of hepatic hemangioma was made. The infant’s
mild cardiac insufficiency was treated with furosemide and
dopamine, and his cardiomegaly gradually improved. The
postnatal course remained uncomplicated, and the hema-
tological parameters remained normal. The neonate was
discharged home on Postpartum Day 18. Follow-upFig. 5 Chest radiography immediately after birth showing
cardiomegaly.sonography after 3 months showed no remarkable change in
the size and echogenicity of the liver lesion, despite pro-
pranolol treatment.
Discussion
Hemangiomas are benign neoplasms and the most common
hepatic tumors in neonates and children [2]. In children,
they can be classified as either infantile or congenital
hemangiomas. Because biopsy may result in massive hem-
orrhage, the diagnosis is usually based on characteristic
radiological findings. The differential diagnosis of a hepatic
mass includes hemangioma, mesenchymal hamartoma,
hepatoblastoma, metastatic neuroblastoma, and embry-
onal sarcoma. On MRI, hemangiomas appear as hypointense
tumors on T1-weighted imaging and as relatively marked
hyperintense masses on T2-weighted imaging. They also
display a characteristic contrast enhancement after gado-
linium administration [5]. Antenatal detection of this lesion
is uncommon.
Although hepatic hemangiomas are usually asymptomatic
and display spontaneous regression, larger tumors can lead
to serious complications such as high-output cardiac insuf-
ficiency and consumptive coagulopathy. Hepatic artery
embolization reduces blood flow through the hepatic artery.
Therefore, it has been an effective treatment for high-
output cardiac insufficiency and consumptive coagulopathy
[1]. Postnatal surgery can increase the risk of complications
and is not advised for the treatment of neonatal hepatic
hemangiomas, but corticosteroid treatment and proactive
therapy for congestive heart failure are helpful [6].
Recently, studies have suggested that propranolol is effec-
tive for the treatment of hemangiomas. The mechanism of
action of propranolol in the treatment of hemangiomas has
explained its potential for vasoconstriction in hemangiomas,
decreasing expression of vascular endothelial growth factor
and basic fibroblast growth factor genes through down-
regulation of the RAF-mitogen-activated protein kinase
pathways, and triggering of apoptosis of capillary endothe-
lial cells [7,8]. The eponymous KasabacheMerritt syndrome
was first described in 1940, when the clinicians evaluated a
newborn male with a rapidly enlarging capillary hemangio-
ma, increasingly extensive purpura of the skin, and throm-
bocytopenia [9]. KasabacheMerritt syndrome is a life-
threatening disorder in which a hemangioma traps and
Fig. 6 Transverse magnetic resonance imaging showing T1-weighted hypointense masses with relatively marked hyperintensity
on T2-weighted images and contrast enhancement after gadolinium administration.
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tally, the diagnosis is established based on the classic triad
of a vascular tumor, thrombocytopenia, and a hemorrhagic
diathesis. Conventional therapy includes administration of
corticosteroids, platelets, and clotting factors. This syn-
drome can occur during antenatal life, and clinicians should
keep it in mind if an extensively vascularized tumor is
observed in a fetus. However, the grayscale and Doppler
sonographic appearances of a fetal lesion do not predict the
presence or severity of hematological abnormalities. Cord-
blood sampling can provide useful information for parental
counseling and for planning appropriate perinatal care
[10e14]. Unfortunately, even with treatment, this condition
may still be fatal. Morimura et al [15] reported an infant
with a hepatic hemangioma and KasabacheMerritt syndrome
that died 2 days after birth. Diagnosing a hepatic hemangi-
oma during the antenatal period gives clinicians time to
familiarize themselves with KasabacheMerritt syndrome, or
to find a skilled consultant, and is therefore important in
determining proper perinatal management and in guiding
parental counseling.
High-output cardiac insufficiency is another possible
complication of giant hepatic hemangiomas, with the pre-
dominant underlying mechanism being massive arteriove-
nous shunting inside the neoplasm. Antenatal signs can be
attributed to increased blood flow with consequent fetal
cardiac insufficiency, but, like the neoplasm itself, this
complication is rarely seen in the antenatal period [16].
End-stage fetal heart failure results in hydrops fetalis. On
antenatal ultrasonographic examination, high-output car-
diac insufficiency is suggested by cardiomegaly (cardio-
thoracic area ratio > 0.35) and fluid accumulation [17].
Elevated systolic peak velocity in the descending aorta can
also be seen by Doppler examination. These conditions
exhibit gradual change; therefore, serial sonographic
follow-up is needed.
The diagnosis of fetal hepatic hemangioma in the ante-
natal period is extremely rare. In 2003, Pott Ba¨rtsch et al
[18] performed an extensive literature review and extrac-
ted 16 reports of fetal giant hemangiomas. The sonographic
appearance of a hepatic hemangioma is a well-defined,
well-circumscribed, mixed solid and cystic lesion of vary-
ing diameter. Punctate calcifications are seen in 50% oflesions [1,5]. Hemangiomas may include echogenic septae
and cystic areas very similar to mesenchymal hamartomas,
but hamartomas are predominantly avascular when inves-
tigated using Doppler. Hemangiomas will demonstrate a
high vascular flow. Each of the fetuses described in the
present series had a solid abdominal mass with several
cystic areas and small punctate calcifications; Doppler ex-
amination confirmed the vascular nature of the lesions.
Other typical color Doppler findings are enlarged feeding
and draining vessels. Associated findings suggestive of the
diagnosis are a dilated hepatic artery and hepatic veins,
cardiomegaly, or evidence of cardiac failure. These findings
correspond positively with the vascularity of the neoplasm.
Many investigators have reported a high incidence of right-
lobe involvement across all liver neoplasms [9]; however,
no explanation for this finding has been reported. In our
second patient, the lesion originated from the left lobe.
This unusual location initially confounded our prenatal
diagnosis; however, the vascular connections seen on
Doppler imaging revealed the correct diagnosis.
We encountered two patients with a giant hepatic
hemangioma, diagnosed during the antenatal period. As in
the postnatal period, the clinical presentation of a hepatic
hemangioma during fetal life is highly variable. Giant he-
patic hemangiomas can lead to life-threatening complica-
tions such as cardiac insufficiency and KasabacheMerritt
syndrome, and these complications may occur during the
fetal or early neonatal period. Accurate prenatal diagnosis
and serial sonographic follow-up allow for proper timing of
delivery and prompt postnatal therapy.References
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